Kari Remes
Professor
Areas of expertise
Clinical haematology; Bone marrow transplantation
Clinical haematology; Bone marrow transplantation
Teaching
Hematologian luennointi ja seminaarit (C6 ja C11). Hematologian ryhmäopetus (C6). Hematologisten syventävien opinnäytteiden ohjaus.
Publications
- Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group (2024)
- Journal of patient-reported outcomes
(A1 Refereed original research article in a scientific journal) - Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients (2024)
- Bone Marrow Transplantation
(A1 Refereed original research article in a scientific journal) - Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group (2022)
- European Journal of Haematology
(A1 Refereed original research article in a scientific journal) - Luovuttajan lymfosyytti-infuusiot allogeenisen kantasolujen siirron jälkihoidossa (2022)
- Duodecim
(A1 Refereed original research article in a scientific journal) - A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide (2020)
- Clinical Lymphoma, Myeloma and Leukemia
(A1 Refereed original research article in a scientific journal) - Allogeeniset kantasolusiirrot soveltuvat iäkkäillekin (2018)
- Duodecim
(A1 Refereed original research article in a scientific journal) - Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013 (2018)
- PLoS ONE
(A1 Refereed original research article in a scientific journal) - Severe neutropenia after rituximab-treatment of multiple sclerosis (2018)
- Multiple Sclerosis and Related Disorders
(A1 Refereed original research article in a scientific journal) - Geenimutaatioon kohdennettu hoito parantaa akuutin myelooisen leukemian (AML) hoitotuloksia (2017)
- Duodecim
(Other publication) - HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia (2017)
- Leukemia
(A1 Refereed original research article in a scientific journal)



